Differential temperature dependencies of antioxidative enzymes in two contrasting species: Fagus sylvatica and Coleus blumei
Importantly, we detected G3BP1 + granular structures also in the cytosol of human pancreatic -cells of a non-diabetic living donor, supporting the physiological roles of these cytosolic organelles
Over 26 weeks, cagrilintide demonstrated dose-dependent weight loss with the 4.5 mg dose achieving approximately 10.8% reduction compared to 3.0% with placebo
Treatment of cholinesterase poisoning from organophosphorus or carbamate insecticides
Cagrilintide, the second generation (2020s) Novo Nordisk took the Pramlintide concept and applied the same half-life extension strategy that they used with Semaglutide: Kept the proline substitutions (anti-amyloid) Added a C20 fatty diacid via a -Glu linker to a lysine residue, albumin binding Additionally stabilized the N- and C-terminal positions Result: Cagrilintide with a half-life of 6.6 days (vs 50 minutes for Pramlintide)
It works by encouraging new blood vessel development, supporting the cells involved in soft tissue repair, and moderating inflammatory signaling that can delay healing